{"schema_version":"1","generated_at":"2026-10-28T07:47:46.718Z","data_as_of":null,"url":"https://www.findmykol.com/kol/stephen-simko","json_url":"https://www.findmykol.com/kol/stephen-simko/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"stephen-simko","name":"Stephen Simko","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Palo Alto","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1861539124","orcid":"0000-0002-4790-4117","openalex":"A5023310582"},"summary":"Stephen Simko is an Oncology physician. OpenAlex indexes 21 publications with 1,700 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":21,"cited_by_count":1700,"h_index":14,"latest_activity_year":2025,"source":"works"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"<i>BRAF</i> V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024026671","status":"verified"},{"title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","year":2024,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(24)01774-4","status":"verified"},{"title":"Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-198452","status":"verified"},{"title":"Primary Results of Patient-Reported Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) Versus Rituximab Plus GemOx (R-GemOx) from the Phase III Starglo Study","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-198424","status":"verified"},{"title":"Evaluation of Anti-Tumor Activity and Impact on T Cell Activation of Glofitamab in Combination with Gemcitabine and Oxaliplatin (Glofit-GemOx)","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-200753","status":"verified"}],"source":"works"},"contact":{"address_1":"725 WELCH RD","city":"Palo Alto","state":"CA","zip":"943041601","phone":"650-497-8000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1861539124","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":27}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-16","provider_certified":"2024-04-16","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}